-
KAT2A: Key Biomarker in Lung Cancer Growth
13 Nov 2025 02:05 GMT
… targeted therapies.
Lung adenocarcinoma (LUAD) remains … driver in lung adenocarcinoma, with compelling ramifications … in understanding lung adenocarcinoma’s pathogenesis. … tumor tissuesKAT2A lung cancer biomarkerlung adenocarcinoma researchoncogenic pathways …
-
Non-Small Cell Lung Cancer Therapeutics Market to Reach US$ 64.92 Billion by 2033 | Datam Intelligence
12 Nov 2025 13:38 GMT
… immunotherapy, and rising lung cancer prevalence
LOS ANGELES … lung-cancer-therapeutics-market
Market Drivers:
✅ Rising Lung Cancer …
By Type (Adenocarcinoma, Squamous Cell Carcinoma … Cell Lung Cancer Therapeutics Market
lung cancer therapeutics …
-
Lifelines from Taiwan: Redefining Lung Cancer Care
12 Nov 2025 03:10 GMT
… direction.
The incidence of lung cancer in Taiwan no longer … that adenocarcinoma accounts for about 70% of all lung cancer cases in … for studying never-smoker lung cancer in East Asian women … designed to detect high-risk lung cancer at early stages — …
-
‘Shine a Light’ Event Highlights Lung Cancer Survivors and Awareness
11 Nov 2025 16:55 GMT
… to commemorate November as Lung Cancer Awareness Month.
The evening … diagnosed with non-small cell adenocarcinoma in 2011.
“I … to her work in lung cancer advocacy, including years of … common misconceptions is that lung cancer only affects older smokers, …
-
The Intricate Web of MicroRNAs in Modulating EGFR-TKI Resistance in Non-Small Cell Lung Cancer: A Comprehensive Review
11 Nov 2025 07:13 GMT
… cell lung cancer (NSCLC) patients, particularly those with adenocarcinoma, … osimertinib resistance in lung cancer by inhibiting the … sensitizing EGFR mutations in lung cancer activate anti-apoptotic … non-small cell lung cancer. Transl Lung Cancer Res. 2022; …
-
BioAtla, Inc. (NASDAQ:BCAB) Q3 2025 Earnings Call Transcript
14 Nov 2025 13:52 GMT
… mutant KRAS non-small cell lung cancer patients. With that, I … EpCAM is broadly expressed across adenocarcinomas of the colon, stomach, … cell engager in advanced adenocarcinomas at the annual 2025 … KRAS non-small cell lung cancer from our other ongoing …
-
Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
13 Nov 2025 21:01 GMT
… in patients with pancreatic ductal adenocarcinoma (“PDAC”), fewer disease progressions … other indications including mKRAS positive lung cancer and other mKRAS positive … other indications, including mKRAS positive lung cancer, other mKRAS positive cancers and …
-
<![CDATA[Imneskibart Plus Aldesleukin Yield Antitumor Activity in Melanoma and NSCLC]]>
13 Nov 2025 19:04 GMT
… and non–small cell lung cancer (NSCLC).1
The findings … -year-old woman with adenocarcinoma who had progressed on … melanoma and non-small cell lung cancer. News release. BioSpace. Published … melanoma and non-small cell lung cancer (NSCLC). Presented at: Society …
-
Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
13 Nov 2025 13:25 GMT
… , non-squamous, non-small cell lung cancer (NSCLC) and progressive disease, despite … .
CAN-2409 – Non-Small Cell Lung Cancer (NSCLC)
Following a positive end … non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC), and a …
-
<![CDATA[Dr Camidge on the Efficacy and Safety of Neladalkib in ALK+ Solid Tumors]]>
13 Nov 2025 03:20 GMT
… it is in lung cancer in that same setting … of Colorado Health Lung Cancer Clinic and the … histologies beyond non–small cell lung cancer (NSCLC), Camidge stated. … subsets such as colorectal adenocarcinoma, pancreatic adenocarcinoma, various sarcomas, …